“The rating action reflects our view of ProMedica’s expected weaker operating performance over the next couple of years and an expectation of potentially lighter-than-historical margins over the medium term,” said S&P analyst Suzie Desai.
The outlook is stable, reflecting S&P’s view of ProMedica’s leading business position and ongoing strategic investments.
More articles on healthcare finance:
Local council approves refinancing plan for Wagoner Community Hospital
5 must-reads on RCM improvement
This week’s 5 must-reads for hospital CFOs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
